Search results
Top 10 world’s most liveable cities in 2024
Indian Express· 8 hours agoCurious about the most desirable cities to live in the world? Find out which cities make the cut and why they shine as the best places to call home.
US Independence Day 2024: 10 Fun Facts About America
NDTV· 8 hours agoUS Independence Day 2024: Known for its cultural diversity and lack of an official language, the US hosts people speaking over 350 languages. With a rich...
Bansal Wire IPO: Should you subscribe to it? Know all about it here | Business Insider India
Business Insider India· 8 hours ago, which manufactures stainless steel wires, opens for subscription today and will remain till July...
Two bold ideas to change the energy industry forever
Utility Dive· 8 hours agoNow may be an ideal time to make dramatic, fundamental changes to how we transport electricity, deliver it to customers and fund new projects, writes...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 8 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
Taiwan sales fall 2% in June
Just Auto· 9 hours agoThe vehicle market this year has come up against strong year earlier volume while imports from Europe were affected by significant shipping delays...
LatentView Analytics buys 70% stake in Decision Point for $39.1 mn
Business Standard India· 9 hours agoLatentView Analytics, a Chennai-based digital analytics consulting and solutions company, has...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 9 hours agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Business Standard India· 9 hours agoShares of pharmaceutical companies were in focus, and rallied up to 12 per cent on the BSE in...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 9 hours agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...